Business Concept /

Development, production and worldwide marketing and sales of biomedical research reagents and -diagnostics for monitoring of non-cellular components of the immune system using blood analysis kits.

History /

 

1989

1991

1998
2002
2004
2004

Pilot project at the Austrian Boehringer Ingelheim subsidiary, for commercial exploitation of spin-off reagents.
Launch of the first products under the trademark
Bender MedSystems®.
Foundation of Bender MedSystems GmbH
Launch of proprietary Instant ELISA® technology
Launch of FlowCytomix technology
Foundation of US subsidiary

Bender MedSystems Laboratory